site stats

News for viking therapeutics

Witryna10 kwi 2024 · Investors in Viking Therapeutics Inc (Symbol: VKTX) saw new options become available today, for the July 21st expiration. One of the key inputs that goes … Witryna1 dzień temu · What happened. Shares of CRISPR Therapeutics ( CRSP 16.66%) were up 15% Thursday morning, a day after a drug-pricing group said the company's single …

Viking Therapeutics Announces Closing of Public Offering of …

WitrynaVKTX Stock News VKTX - Viking Therapeutics Inc. 07/22/20 4:05 PM. Nasdaq: VKTX. conferences earnings. Viking Therapeutics to Report Financial Results for Second Quarter 2024 on July 29, 2024. ... Viking Therapeutics is a clinical-stage biopharmaceutical company focused on the development of novel, orally available, … Witryna5 kwi 2024 · In terms of liquidity and interest, the mean open interest for Viking Therapeutics options trades today is 554.14 with a total volume of 5,211.00. In the following chart, we are able to follow the ... cleveland to athens greece https://whatistoomuch.com

Viking Therapeutics to Present at 22nd Annual Needham …

Witryna2 dni temu · SAN DIEGO, April 11, 2024 /PRNewswire/ -- Viking Therapeutics Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that its chief executive officer, Brian Lian, Ph.D., will deliver a corporate presentation … Witryna14 kwi 2024 · Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Rating) CFO Greg Zante sold 56,295 shares of Viking Therapeutics stock in a transaction dated Tuesday, April 11th.The stock was sold at an average price of $18.00, for a total transaction of $1,013,310.00. Following the completion of the sale, the chief financial officer now … Witryna2 dni temu · Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for … cleveland to akron flights

Viking Therapeutics, Inc. (NASDAQ:VKTX) CEO Brian Lian Sells …

Category:Kintara Therapeutics Announces Data Presentation at the 2024 …

Tags:News for viking therapeutics

News for viking therapeutics

BRIEF-Viking Therapeutics says statistically significant reductions …

Witryna11 kwi 2024 · The conference will take place April 17-20, 2024. Details for this presentation are as follows: 22nd Annual Needham Healthcare Conference. Details: Viking management will deliver a corporate presentation and participate in 1-on-1 meetings. Conference Dates: April 17-20, 2024. Presentation Timing: 10:15 a.m. … Witryna11 kwi 2024 · Die Viking Therapeutics Inc Aktie wird unter der ISIN US92686J1060 an den Börsen Frankfurt, Düsseldorf, München, Stuttgart, Berlin, NASDAQ, London, Bats, NASDAQ Bsc, Gettex, Tradegate, Lang ...

News for viking therapeutics

Did you know?

WitrynaGet the latest Viking Therapeutics Inc (VKTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and … Witryna11 kwi 2024 · The trading price of Viking Therapeutics Inc. (NASDAQ:VKTX) closed higher on Monday, April 10, closing at $16.94, 1.56% higher than its previous close. …

Witryna11 kwi 2024 · Finance. Industry. Market http://ir.vikingtherapeutics.com/2024-04-11-Viking-Therapeutics-to-Present-at-22nd-Annual-Needham-Healthcare-Conference

WitrynaStock analysis for Viking Therapeutics Inc (VKTX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Witryna2 dni temu · Meanwhile the share price of Viking Therapeutics - whose NASH candidate VK2809 has a similar mechanism of action ... but the news caused the stock price to fall <$50 and it has failed to recover ...

Witryna11 kwi 2024 · Viking Therapeutics is a clinical-stage biopharmaceutical company focused on the development of novel first-in-class or best-in-class therapies for the treatment of metabolic and endocrine disorders, with three compounds currently in clinical trials. Viking's research and development activities leverage its expertise in …

Witryna3 godz. temu · Along with CRISPR Therapeutics, it could grab 50% of this total, so $32 billion. Of course, that may take years. Also, per its agreement with Vertex, CRISPR … cleveland to atlWitryna13 kwi 2024 · -- Brian Lian, directeur, président et PDG, a vendu le 13 avril 2024 79 336 actions de Viking Therapeutics pour un montant de 1 463 749 dollars. Suite au dépôt du formulaire 4 auprès de la SEC ... cleveland to asheville nc drivingWitryna11 kwi 2024 · The trading price of Viking Therapeutics Inc. (NASDAQ:VKTX) closed higher on Monday, April 10, closing at $16.94, 1.56% higher than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $16.16 and $17.1657. In examining the 52-week pric bmo harris bank bonus offerWitryna2 dni temu · SAN DIEGO, April 11, 2024 /PRNewswire/ -- Viking Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the development of novel … cleveland to aruba airfareWitryna29 gru 2024 · Viking Therapeutics accuses Chinese co of stealing fatty liver disease drug secrets By Blake Brittain The logo of Ascletis Pharma Inc. is seen at a news … bmo harris bank bonusWitryna22 godz. temu · Viking Therapeutics Announces Closing of Public Offering of Common Stock And Full Exercise of Underwriters' Option to Purchase Additional Shares 04/03/23-5:06PM EST PR Newswire. More Other News ... cleveland to atlanta driveWitryna4 mar 2024 · Shares of NASDAQ VKTX opened at $11.83 on Thursday. Viking Therapeutics has a 52-week low of $2.02 and a 52-week high of $11.98. The firm has a 50 day moving average price of $9.61 and a two ... cleveland to asheville nc